SCHEMBL22097083

SCHEMBL22097083

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4c(c3)c3ccccc3c3c4ccc4c3c3ccccc3n4-c3ccccc3)n2)cc1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.42
ATM Q13315 2/20 0.42
KDM4E B2RXH2 1/20 0.42
PTGER4 P35408 1/20 0.35
KMT2A Q03164 5/20 0.35
IL1R1 P14778 1/20 0.35
MEN1 O00255 4/20 0.34
ALDH1A1 P00352 2/20 0.34
MAPT P10636 2/20 0.34
HPGD P15428 1/20 0.34
HTT P42858 1/20 0.34
ABCG2 Q9UNQ0 1/20 0.34
JAK2 O60674 1/20 0.33
JAK3 P52333 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
NPC1 O15118 1/20 0.33
LMNA P02545 1/20 0.33
RAB9A P51151 1/20 0.33
AVPR1A P37288 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22097076 1.00 L3MBTL1 (0.42) L3MBTL1ATMKDM4EPTGER4KMT2A
SCHEMBL22097261 0.99 L3MBTL1 (0.41) L3MBTL1ATMKDM4EPTGER4KMT2A
SCHEMBL22096963 0.99 L3MBTL1 (0.41) L3MBTL1ATMKDM4EPTGER4KMT2A
SCHEMBL22097148 0.93 MAPT (0.39) L3MBTL1ATMKDM4EPTGER4KMT2A
SCHEMBL20226341 0.93 KDM4E (0.36) L3MBTL1ATMKDM4EPTGER4KMT2A
SCHEMBL22097243 0.93 KDM4E (0.41) L3MBTL1ATMKDM4EPTGER4KMT2A
SCHEMBL18126018 0.92 L3MBTL1 (0.47) L3MBTL1ATMKDM4EPTGER4KMT2A
SCHEMBL20226326 0.92 L3MBTL1 (0.43) L3MBTL1ATMKDM4EKMT2AIL1R1
SCHEMBL22096968 0.91 MEN1 (0.40) L3MBTL1ATMKDM4EPTGER4KMT2A
SCHEMBL22097056 0.91 MEN1 (0.40) L3MBTL1ATMKDM4EPTGER4KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11236075-B2 Organic compound and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2022-02-01 US disclosed
US-20200190065-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11236075-B2 Organic compound and organic electroluminescence device using the same ICMT, OR10J3, PIEZO1 L3MBTL1 179/4885ATM 3884/4885KDM4E 1846/4885
US-20200190065-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME ICMT, OR10J3, PIEZO1 L3MBTL1 179/4885ATM 3884/4885KDM4E 1846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.